For at reducere den potentielle risiko for lave ACT- værdier skal det opløste og fortyndede produkt opblandes grundigt før anvendelsen og bolusdosis skal indgives hurtigt intravenøst.
In order to reduce the potential for low ACT values, the reconstituted and diluted product should be thoroughly mixed prior to administration and the bolus dose administered by a rapid intravenous push.